When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options

Expanding evidence on SGLT2i: Where are we now and what can we expect?
Expanding evidence on SGLT2i: Where are we now and what can we expect?
When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options
Expanding evidence on SGLT2i: Where are we now and what can we expect?
- Scott Solomon, MD
Discussion - When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options
Discussion - When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options
When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options
Discussion - When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options
Benefits and evolving insights on SGLT2i in the spectrum of LVEF
Benefits and evolving insights on SGLT2i in the spectrum of LVEF
When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options
Benefits and evolving insights on SGLT2i in the spectrum of LVEF
- Prof. Carolyn Lam, MD
The clinical challenges of initiating guideline recommended therapy in HF
The clinical challenges of initiating guideline recommended therapy in HF
When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options
The clinical challenges of initiating guideline recommended therapy in HF
- Prof. John McMurray, MD